27: fatty acid degradation

What is the big picture of Chapter 27 — why does fatty acid degradation matter?

Fat is the body's most energy-dense fuel. A single 16-carbon fatty acid (palmitate) yields ~106 ATP — compared to ~30-32 ATP from one glucose molecule. Fat stores are also much larger than glycogen stores. The two clinical cases that frame this chapter: (1) A woman snowed in for days with no food maintained normal brain function using fat-derived ketone bodies. (2) Angus Barbieri fasted for 382 days under medical supervision, losing 276 lbs, with stable blood glucose throughout — sustained entirely by stored fat. Chapter 27 explains HOW the body accesses and burns that fat. There are three stages: lipolysis in adipose tissue → activation and transport into mitochondria → beta-oxidation in the mitochondrial matrix.

Why is fat a superior energy reserve compared to glycogen?

Two reasons: (1) Energy density: Fat yields ~37 kJ/g; glycogen yields ~4 kJ/g — fat has about 9× more energy per gram. Fat is also essentially ANHYDROUS (no water attached), while glycogen is heavily hydrated (each gram of glycogen carries ~2g of water). So the actual difference in stored energy per unit of body weight is even larger. (2) Carbon-level efficiency: Palmitate (16C) yields ~6.6 ATP per carbon; glucose (6C) yields ~5.2 ATP per carbon — fat is ~25% more energy-efficient per carbon because fatty acid carbons are more reduced (more hydrogens attached) and undergo more oxidations. Trade-off: fat mobilization is slower and requires more enzymatic steps than glycogen mobilization.

What is Stage 1 of fatty acid processing — lipolysis? Where does it happen and what triggers it?

Lipolysis is the hydrolysis of stored triacylglycerols (TAGs — glycerol backbone with 3 fatty acid chains) into free fatty acids and glycerol. It happens in ADIPOSE TISSUE (subcutaneous fat under the skin and visceral fat around organs). Trigger: When energy is needed, glucagon or epinephrine binds to a G-protein coupled receptor on the adipocyte surface → activates adenylyl cyclase → raises cAMP → activates PKA. PKA phosphorylates TWO targets: (1) Perilipin — a protein coating the lipid droplet that normally protects TAGs from random hydrolysis. Phosphorylated perilipin releases its protective grip, exposing the lipid droplet. (2) Hormone-Sensitive Lipase (HSL) — directly activated by PKA phosphorylation. Note: This is the SAME cAMP-PKA cascade as glycogen breakdown — one hormonal signal mobilizes BOTH fuel stores simultaneously.

What are the three lipases that sequentially break down a triacylglycerol, and why are three needed?

Three separate lipases are needed because the three fatty acid positions on glycerol (sn-1, sn-2, sn-3) have different geometries requiring different enzyme specificities: (1) ATGL (Adipose Triglyceride Lipase) — performs the FIRST cut: TAG → diacylglycerol (DAG) + 1 fatty acid. (2) HSL (Hormone-Sensitive Lipase) — performs the SECOND cut: DAG → monoacylglycerol (MAG) + 1 fatty acid. HSL is the hormonally regulated enzyme — it is directly activated by PKA phosphorylation. (3) MAG Lipase (Monoacylglycerol Lipase) — performs the THIRD cut: MAG → glycerol + 1 fatty acid. After all three cuts: 1 glycerol + 3 free fatty acids are released from the adipocyte.

What happens to glycerol after lipolysis? Where does it go and what happens to it?

Glycerol is water-soluble, so it travels freely in the bloodstream to the LIVER (adipose tissue lacks the enzyme glycerol kinase and cannot recycle its own glycerol). In the liver, glycerol kinase phosphorylates glycerol using ATP → glycerol-3-phosphate. Glycerol-3-phosphate can then: (1) Enter glycolysis (toward pyruvate and energy production) — one NADH is generated along the way. (2) Enter gluconeogenesis (toward glucose synthesis) — this is important during fasting as it provides carbon for new glucose. Glycerol's ability to contribute to gluconeogenesis is why even-chain fatty acids technically cannot contribute to net gluconeogenesis but the whole fat molecule can slightly (via glycerol).

How do free fatty acids travel in the blood after lipolysis? Why can't they just dissolve?

Free fatty acids (FFAs) are highly hydrophobic — they cannot dissolve in the aqueous blood plasma. They are carried bound to SERUM ALBUMIN, the most abundant protein in blood. Albumin has hydrophobic binding sites on its surface that can accommodate 6–7 fatty acid molecules at a time, essentially chaperoning them through the bloodstream to target tissues. Upon arriving at a target cell, the fatty acid dissociates from albumin and enters the cell via a fatty acid transporter protein in the plasma membrane. Without albumin, free fatty acids would aggregate and could not be transported in aqueous blood.

What is Stage 2 of fatty acid processing — activation? What enzyme is responsible and what exactly happens?

Once a free fatty acid enters a cell, it must be ACTIVATED before it can be oxidized. Activation happens in the CYTOPLASM. The enzyme fatty acyl-CoA synthetase (also called fatty acid thiokinase) attaches Coenzyme A (CoA) to the fatty acid's carboxyl group via a high-energy thioester bond, forming fatty acyl-CoA. The reaction: Fatty acid + CoA + ATP → fatty acyl-CoA + AMP + PPi. CRITICAL ACCOUNTING DETAIL: ATP is converted all the way to AMP (not ADP). This is equivalent to consuming 2 ATP equivalents (because regenerating ATP from AMP requires 2 phosphate transfers). Pyrophosphatase immediately hydrolyzes PPi → 2 Pi, making the reaction irreversible. This 2-ATP activation cost is the ONLY energy investment in the entire fatty acid degradation process — everything downstream is profit.

EXAM FOCUS — How many ATP equivalents does fatty acid activation cost, and why is this tricky?

The activation costs 2 ATP equivalents — NOT 1. Here is why students get this wrong: The reaction converts ATP → AMP + PPi (not ATP → ADP + Pi). Going from ATP to AMP means losing TWO phosphate bonds (ATP → ADP is one bond; ADP → AMP is a second bond). Regenerating AMP back to ATP requires two separate phosphorylation steps, costing 2 ATP equivalents total. This 2-ATP activation cost must be subtracted when calculating total ATP yield from fatty acid oxidation.

What is the carnitine shuttle and why is it needed?

Fatty acyl-CoA (the activated fatty acid) CANNOT cross the inner mitochondrial membrane because CoA is large and highly charged (polar). The outer mitochondrial membrane is porous and freely permeable, but the inner membrane is nearly impermeable to charged molecules. The carnitine shuttle solves this problem by temporarily swapping CoA for carnitine (a smaller, less charged molecule that has a dedicated transporter). The shuttle has three steps: (1) CPT-I (Carnitine PalmitoyITransferase I) on the OUTER mitochondrial membrane transfers the acyl group from acyl-CoA → carnitine, forming acyl-carnitine and releasing free CoA back into the cytoplasm. (2) A translocase (antiporter) in the INNER membrane carries acyl-carnitine INTO the matrix while simultaneously transporting free carnitine OUT. (3) CPT-II on the MATRIX side of the inner membrane transfers the acyl group back from carnitine → CoA, regenerating acyl-CoA inside the matrix. Free carnitine is recycled back across the membrane.

Why is CPT-I the key regulatory point for fatty acid oxidation?

CPT-I is the gateway enzyme for fatty acid entry into the mitochondria — and it is INHIBITED by malonyl-CoA. Malonyl-CoA is the first committed intermediate of fatty acid SYNTHESIS. This creates elegant reciprocal regulation: when fatty acid synthesis is active (fed state, malonyl-CoA is high) → CPT-I is inhibited → fatty acids cannot enter the mitochondria → oxidation is OFF. When fatty acid synthesis is inactive (fasted state, malonyl-CoA is low) → CPT-I is disinhibited → fatty acids can enter the mitochondria → oxidation is ON. This is the molecular basis for the rule: the cell never synthesizes and degrades fat simultaneously. One molecule (malonyl-CoA) controls both directions.

What is the compartmentalization principle for fatty acid metabolism?

Fat synthesis (anabolism) occurs in the CYTOPLASM using cytoplasmic CoA and NADPH as the reductant. Fat degradation (catabolism) occurs in the MITOCHONDRIAL MATRIX using matrix CoA and produces NADH and FADH₂. These separate pools of CoA in two different compartments allow the cell to regulate synthesis and degradation independently and simultaneously. The carnitine shuttle acts as the border control between compartments. This compartmentalization is what prevents the two opposing pathways from colliding and creating a futile cycle.

What is Stage 3 of fatty acid processing — beta-oxidation? Where does it occur and what is the overall goal?

Beta-oxidation occurs in the MITOCHONDRIAL MATRIX. The goal is to systematically dismantle the fatty acyl-CoA chain TWO CARBONS AT A TIME, producing acetyl-CoA units that feed directly into the citric acid cycle. It is called "beta-oxidation" because the chemistry targets the BETA carbon — the carbon that is second away from the carbonyl (carboxyl) end of the chain. Carbon numbering: C1 = carbonyl carbon, C2 = alpha carbon, C3 = beta carbon, and so on. Each round of beta-oxidation shortens the chain by 2 carbons and produces: 1 FADH₂ + 1 NADH + 1 acetyl-CoA.

Walk through the FOUR steps of beta-oxidation in order. Name each enzyme and what it does.

Remember these four steps in order: Oxidation → Hydration → Oxidation → Thiolysis. Step 1 — OXIDATION (FAD): Acyl-CoA dehydrogenase removes two hydrogens from the acyl-CoA using FAD as the electron acceptor (producing FADH₂). This creates a trans-Δ2 double bond between C2 and C3 (between the alpha and beta carbons). Product: trans-Δ2-enoyl-CoA. Step 2 — HYDRATION: Enoyl-CoA hydratase adds water across the double bond, placing a hydroxyl (-OH) group specifically on C3 (the beta carbon) and a hydrogen on C2. Product: L-3-hydroxyacyl-CoA. Step 3 — OXIDATION (NAD+): L-3-hydroxyacyl-CoA dehydrogenase oxidizes the hydroxyl group at C3 → a keto group (C=O), using NAD+ as the electron acceptor (producing NADH). Product: 3-ketoacyl-CoA. Step 4 — THIOLYSIS: Beta-ketothiolase cleaves the bond between C2 and C3 using a free CoA molecule (via its reactive sulfhydryl -SH group). This releases a 2-carbon ACETYL-CoA unit AND regenerates a new acyl-CoA that is 2 carbons shorter. This shorter acyl-CoA then re-enters the cycle.

What does each round of beta-oxidation produce?

Each complete round of beta-oxidation produces: 1 FADH₂ (from Step 1, worth ~1.5 ATP via oxidative phosphorylation), 1 NADH (from Step 3, worth ~2.5 ATP via oxidative phosphorylation), 1 acetyl-CoA (enters the TCA cycle — worth ~10 ATP per acetyl-CoA through the full TCA cycle). The chain is also shortened by 2 carbons, ready for the next round.

Walk through the complete ATP accounting for palmitate (C16:0) oxidation.

Palmitate has 16 carbons. Beta-oxidation goes through 7 complete rounds, releasing 7 acetyl-CoA and leaving one final 2-carbon acetyl-CoA from the last round — total of 8 acetyl-CoA. Energy accounting: Activation cost: −2 ATP (ATP → AMP + PPi). From 7 rounds of beta-oxidation: 7 FADH₂ × ~1.5 ATP = 10.5 ATP. 7 NADH × ~2.5 ATP = 17.5 ATP. From 8 acetyl-CoA entering TCA cycle: 8 × ~10 ATP = 80 ATP. GRAND TOTAL: −2 + 10.5 + 17.5 + 80 = ~106 ATP net. Compare to glucose: ~30-32 ATP. Per carbon: palmitate gives ~6.6 ATP/carbon vs. glucose ~5.2 ATP/carbon. Fat is ~25% more energy-efficient per carbon.

How many rounds of beta-oxidation does palmitate (C16) undergo, and how do you calculate this for any even-chain fatty acid?

Palmitate undergoes 7 rounds. The formula for any even-chain saturated fatty acid is: Number of rounds = (number of carbons ÷ 2) − 1. For palmitate: (16 ÷ 2) − 1 = 7 rounds. Number of acetyl-CoA produced = number of carbons ÷ 2 = 8 acetyl-CoA. Why n/2 − 1 rounds but n/2 acetyl-CoA? Because the last round produces 2 acetyl-CoA simultaneously (the 4-carbon butyryl-CoA is cleaved directly into 2 acetyl-CoA in the final round), so you get one extra acetyl-CoA compared to the number of rounds.

What are the acyl-CoA dehydrogenase isozymes, and which is clinically most important?

Acyl-CoA dehydrogenase (the enzyme for Step 1 of beta-oxidation) is actually a FAMILY of isozymes, each specific for different chain lengths: SCAD — Short Chain Acyl-CoA Dehydrogenase (C4–C6 chains). MCAD — Medium Chain Acyl-CoA Dehydrogenase (C6–C12 chains). LCAD — Long Chain Acyl-CoA Dehydrogenase. VLCAD — Very Long Chain Acyl-CoA Dehydrogenase. MCAD DEFICIENCY is the most clinically important — it is the most common inborn error of fatty acid oxidation (~1 in 10,000 births in European populations).

Describe MCAD deficiency — presentation, mechanism, and how it is caught.

MCAD (Medium Chain Acyl-CoA Dehydrogenase) deficiency: Enzyme affected: MCAD — cannot process medium-chain fatty acids (C6-C12). When it presents: Babies appear COMPLETELY HEALTHY at birth. The problem emerges only during fasting/illness (when glycogen stores are exhausted and the body MUST rely on fat oxidation). Mechanism: Without MCAD, beta-oxidation stalls at medium-chain intermediates. The body cannot produce ketone bodies (HYPOKETOTIC HYPOGLYCEMIA is the classic finding). Blood glucose crashes without ketones to substitute for the brain. Symptoms: Seizures, coma, and historically — death (many were misclassified as SIDS — Sudden Infant Death Syndrome). Trigger: A routine viral illness that causes the baby to stop eating for 12–24 hours. Diagnosis: Tandem mass spectrometry of newborn heel-prick blood sample — detects abnormal acylcarnitine profiles. Today, all 50 U.S. states screen for MCAD at birth. Treatment: Simply ensure the baby NEVER goes prolonged periods without eating — this alone is essentially curative, with normal prognosis.

What is hypoketotic hypoglycemia and why does MCAD deficiency cause it specifically?

In normal fasting: blood glucose drops → liver mobilizes fatty acids → beta-oxidation produces acetyl-CoA → ketone bodies are made from excess acetyl-CoA → brain switches to ketones as fuel. This maintains brain function even without glucose. In MCAD deficiency: fatty acids begin to be processed, but stall at the medium-chain step. NO acetyl-CoA accumulates → NO ketone bodies are produced. The brain gets no ketone body backup. Blood glucose crashes AND there are no ketones to compensate → "hypoketotic hypoglycemia" (low glucose + abnormally low ketones). This combination is what causes the neurological crisis. The "hypoketotic" part is the key distinguishing feature — in starvation hypoglycemia, ketones rise; in MCAD deficiency, they do not.

How does beta-oxidation handle monounsaturated fatty acids (those with ONE double bond)?

The problem: Beta-oxidation Step 1 creates a TRANS-Δ2 double bond. But natural unsaturated fatty acids have CIS double bonds at various positions. When beta-oxidation cycles through the chain and a pre-existing cis double bond ends up at the Δ3 position, the normal machinery stalls. The solution: ONE extra enzyme — cis-Δ3-enoyl-CoA isomerase. This enzyme repositions and reorients the cis-Δ3 double bond → trans-Δ2 double bond (the exact geometry that enoyl-CoA hydratase in Step 2 needs). After this isomerization, normal beta-oxidation continues without interruption. ONE extra enzyme handles all monounsaturated fatty acids.

How does beta-oxidation handle polyunsaturated fatty acids (those with TWO OR MORE double bonds)?

Polyunsaturated fatty acids require TWO extra enzymes (not just one like monounsaturated): When beta-oxidation produces a 2,4-dienoyl-CoA (a conjugated diene intermediate from a polyunsaturated fatty acid), a second enzyme is needed: (1) 2,4-dienoyl-CoA REDUCTASE — uses NADPH to reduce the intermediate. (2) Then cis-Δ3-enoyl-CoA ISOMERASE — converts the resulting trans-Δ3 bond to trans-Δ2, allowing normal beta-oxidation to continue. DECISION RULE (exam-worthy): Fatty acids with an ODD number of double bonds need only the ISOMERASE. Fatty acids with an EVEN number of double bonds need BOTH the reductase AND the isomerase.

What happens when beta-oxidation reaches an odd-chain fatty acid? What is the unique product?

Most fatty acids have even numbers of carbons (from 2-carbon acetyl-CoA building blocks). But odd-chain fatty acids (C15, C17, etc. — found in some plant oils and ruminant fat) produce a 3-carbon PROPIONYL-CoA in the very last round of beta-oxidation instead of the usual 2-carbon acetyl-CoA. Normal beta-oxidation cannot process propionyl-CoA directly. It must be converted through two steps: Step 1: Propionyl-CoA carboxylase (requires BIOTIN as a cofactor) converts propionyl-CoA → methylmalonyl-CoA. Step 2: Methylmalonyl-CoA mutase (requires VITAMIN B12 as a cofactor) rearranges methylmalonyl-CoA → SUCCINYL-CoA. Succinyl-CoA is a TCA cycle intermediate that can be used for energy OR for gluconeogenesis (via oxaloacetate). Remember: BIOTIN for step 1, B12 for step 2.

EXAM FOCUS — Why are odd-chain fatty acids the ONLY fatty acids that can contribute net carbon to gluconeogenesis?

Even-chain fatty acids are completely broken down to acetyl-CoA. Acetyl-CoA enters the TCA cycle by combining with oxaloacetate to form citrate, but then TWO carbons are lost as CO₂ before oxaloacetate is regenerated. Net carbon balance = ZERO. No new oxaloacetate is produced, so even-chain fat CANNOT provide net carbon for gluconeogenesis. Odd-chain fatty acids are different: their terminal propionyl-CoA → succinyl-CoA (via biotin and B12), which is a TCA intermediate. Succinyl-CoA feeds into the cycle BEYOND the CO₂ release steps, so it provides a NET input of carbons to the cycle. Excess oxaloacetate CAN exit and feed gluconeogenesis. This makes odd-chain fatty acids uniquely glucogenic among fats.

What are ketone bodies? Name the three main ones.

Ketone bodies are water-soluble fuel molecules made in the LIVER from excess acetyl-CoA during fasting or starvation. They serve as an alternative fuel for the brain (and other tissues) when glucose is scarce. The three ketone bodies: (1) Acetoacetate — the primary ketone body produced. (2) D-3-hydroxybutyrate (beta-hydroxybutyrate) — produced when acetoacetate is reduced by D-3-hydroxybutyrate dehydrogenase using NADH. This is the PREDOMINANT ketone body in the blood during fasting. (3) Acetone — produced by spontaneous decarboxylation of acetoacetate. Acetone is VOLATILE and exhaled — it is the source of the characteristic "fruity breath" in people with high ketone levels (diabetic ketoacidosis or prolonged fasting).

Why does the liver make ketone bodies? Walk through the synthesis pathway.

When fasting is prolonged, fat becomes the primary fuel. The liver performs massive beta-oxidation, producing enormous amounts of acetyl-CoA. The TCA cycle cannot handle all of it because oxaloacetate (which acetyl-CoA must combine with to enter the cycle) becomes limiting — oxaloacetate is being used for gluconeogenesis. Excess acetyl-CoA backs up. The liver solves this by converting excess acetyl-CoA into ketone bodies and exporting them to the blood for other tissues to use. Ketogenesis pathway: Step 1: Thiolase condenses 2 acetyl-CoA → acetoacetyl-CoA. Step 2: HMG-CoA synthase (mitochondrial isoform, HMGCS2) adds a 3rd acetyl-CoA → HMG-CoA. Step 3: HMG-CoA lyase cleaves HMG-CoA → acetoacetate + acetyl-CoA. Step 4: D-3-hydroxybutyrate dehydrogenase (using NADH) reduces acetoacetate → D-3-hydroxybutyrate. Both forms are exported into the blood.

EXAM FOCUS — Why can the liver make ketone bodies but NOT use them?

The liver LACKS the enzyme succinyl-CoA transferase (thiophorase). This enzyme is required to activate acetoacetate back into acetoacetyl-CoA in peripheral tissues so it can be converted to acetyl-CoA and enter the TCA cycle. Without thiophorase, the liver cannot reconvert ketone bodies into usable acetyl-CoA, so it cannot oxidize its own ketones for energy. The liver is exclusively a PRODUCER of ketone bodies — it exports them for other tissues (brain, heart, muscle, kidneys) to burn. This is elegant: the liver is the ketone factory, and peripheral tissues are the ketone consumers.

How do peripheral tissues (brain, muscle, heart) USE ketone bodies?

Ketone body utilization (ketolysis) in peripheral tissues: Step 1: D-3-hydroxybutyrate is oxidized back to acetoacetate by D-3-hydroxybutyrate dehydrogenase (using NAD+, producing NADH). Step 2: Succinyl-CoA transferase (thiophorase) transfers CoA from succinyl-CoA (a TCA intermediate) to acetoacetate → acetoacetyl-CoA + succinate. THIS IS THE STEP THE LIVER LACKS. Step 3: Thiolase cleaves acetoacetyl-CoA → 2 acetyl-CoA. Step 4: Acetyl-CoA enters the TCA cycle → full energy production. Key: Using succinyl-CoA as the CoA donor means the TCA cycle "donates" a CoA to activate the ketone — it is the cost of entry, but well worth it for the acetyl-CoA produced.

What is the fasting fuel hierarchy — how does the body transition from glucose to ketones during prolonged fasting?

The body transitions through predictable stages: Hours 0–8 (Early fasting): Liver glycogen is broken down → blood glucose maintained. Hours 8–24 (Glycogen depletion): Glycogen is exhausted. Gluconeogenesis begins using amino acids from muscle protein and glycerol from fat. Hours 24–72 (Fat mobilization): Fat oxidation ramps up significantly. Liver produces ketone bodies from excess acetyl-CoA. The brain begins accepting ketones. Day 3–40+ (Ketone adaptation): Rising ketone levels progressively supply more brain energy. By day 40, the BRAIN runs ~75% on ketones (up to ~100g/day). Protein catabolism drops dramatically — from ~75g/day early in fasting to ~20g/day — because the brain no longer needs as much glucose from amino acids. The body is now primarily burning fat. Death during prolonged starvation occurs when fat stores are fully depleted and protein catabolism accelerates again, leading to organ failure.

What is the difference between physiological ketosis and diabetic ketoacidosis (DKA)?

PHYSIOLOGICAL KETOSIS (fasting, ketogenic diet): Insulin is still present at low levels. Insulin acts as a BRAKE on ketone production — it limits how fast the liver makes ketones. Ketone levels rise but stay stable (typically 1–7 mM). Blood pH is maintained. The brain uses ketones as efficient fuel. Safe and controllable. DIABETIC KETOACIDOSIS (DKA — Type 1 Diabetes): Insulin is COMPLETELY ABSENT. Without insulin's brake, the liver produces ketones UNCHECKED at a runaway rate. Ketone levels climb dramatically (can reach 20+ mM). Ketone bodies are moderately strong ACIDS — massive accumulation acidifies the blood. A drop in blood pH of just 0.2 units causes coma. Blood pH can fall to 7.0 or below — life-threatening. DKA is a medical EMERGENCY. Key: Insulin is the critical brake. Without it, ketogenesis becomes uncontrolled and dangerous. (Note: DKA patients can have fruity acetone breath — there are cases of DKA patients being arrested for suspected drunk driving.)

How does the ketogenic diet work for epilepsy treatment?

In 1921, Dr. Russell Wilder at the Mayo Clinic observed that fasting reduced seizures and developed the ketogenic diet to mimic fasting biochemically. The diet: very high fat (~70-80% of calories), very low carbohydrate, moderate protein. This forces the body into chronic ketosis — the brain runs primarily on ketone bodies instead of glucose. The mechanism is not fully understood but involves: changes in brain energy metabolism, altered neurotransmitter balance (ketones may increase GABA, an inhibitory neurotransmitter), and reduced neuronal excitability. The diet fell out of favor after anticonvulsant drugs appeared (1938), but was revived in the 1990s through the Charlie Foundation. Today it remains a legitimate medical treatment for drug-resistant epilepsy, especially in children.

What is white adipose tissue (WAT) vs. brown adipose tissue (BAT)?

WHITE ADIPOSE TISSUE (WAT): The familiar "body fat." Stores TAG as large lipid droplets. Primary function: energy storage and mobilization. Exports fatty acids and glycerol during fasting. Found subcutaneously and viscerally. BROWN ADIPOSE TISSUE (BAT): Also performs lipolysis and beta-oxidation, but the goal is NOT to make ATP. BAT contains uncoupling protein 1 (UCP1) in the inner mitochondrial membrane. UCP1 creates a proton LEAK — it allows protons to flow back across the inner membrane WITHOUT going through ATP synthase. This dissipates the proton gradient as HEAT instead of ATP. BAT is a HEAT GENERATOR — important for newborns (who cannot shiver) and hibernating animals. Adults were long thought to have no functional brown fat, but PET imaging studies around 2009 showed adults DO retain active BAT depots, mainly in the neck and shoulders, and BAT activity correlates with metabolic health.

What is the study guide's key point about fat oxidation being mitochondrial and fat synthesis being cytoplasmic, and why does this matter?

This compartmentalization is a CRITICAL exam concept and a common trap. Fat oxidation (beta-oxidation) = MITOCHONDRIAL MATRIX. Uses CoA (matrix pool), produces NADH and FADH₂, requires oxygen indirectly (via ETC). Fat synthesis = CYTOPLASM. Uses a separate CoA (cytoplasmic pool), consumes NADPH (not NADH), runs on ACP (not CoA). Because they are in different compartments with different cofactors (NADPH for synthesis vs. NADH/FADH₂ for oxidation), the cell can run both pathways simultaneously if needed without one interfering with the other. The ONLY shared regulatory point is CPT-I, inhibited by malonyl-CoA — when synthesis is active, malonyl-CoA blocks fatty acid entry into the mitochondria, preventing simultaneous oxidation.

What does the study guide flag as the key exam traps for Chapter 27?

From the Dr. Deppmann study guide: (1) Fat oxidation is MITOCHONDRIAL; fat synthesis is CYTOPLASMIC — different compartments, different cofactors (NAD+/FAD for oxidation vs. NADPH for synthesis). Do NOT mix them up. (2) Acetyl-CoA CANNOT cross the inner mitochondrial membrane directly — it is exported as CITRATE (important for fat synthesis in Ch 28, but worth knowing the principle here). (3) Even-chain fatty acids CANNOT contribute net carbon to gluconeogenesis (all carbons become acetyl-CoA which is a dead end). ODD-chain fatty acids CAN (propionyl-CoA → succinyl-CoA → gluconeogenesis via oxaloacetate). (4) The activation cost is 2 ATP equivalents (ATP → AMP, not ADP). Many students forget and write 1 ATP. (5) The carnitine shuttle: CPT-I is on the OUTER membrane, CPT-II is on the INNER membrane (matrix side). Students often mix these up.